newsfilter
← Latest News
GlobeNewswire·

TCR² Therapeutics to Present at the H.C. Wainwright Global Investment Conference

CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (NASDAQ:TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced that Ian Somaiya, Chief Finan